Back to Startup Insights
Isomorphic Labs
Alphabet-owned AI drug discovery company spun out of Google DeepMind by Demis Hassabis, built on the Nobel Prize-winning AlphaFold platform to design novel medicines end to end.
Headquarters
London, UK
Year Founded
2021
Founders
Sir Demis Hassabis
Country
United Kingdom
Financial Information
Funding Stage
Series B (first external round)
Recent Funding
$600M
Funding By
Thrive Capital, GV, Alphabet
Core Technology
AlphaFold-based generative AI drug design engine
Product Type
Drug + AI Platform
Pipeline Stage (Very Important)
Preclinical
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Strong AlphaFold IP portfolio
Partnerships
Pharma Collaborations
Eli Lilly, Novartis
Academic / Hospital Tie-ups
Google DeepMind
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
AlphaFold heritage; first AI-designed drugs entering human trials